ATE358275T1 - Verfahren und kit zum nachweis, oder zum quantifizieren von, metaboliten von fentanyl und metaboliten von fentanyl analoga - Google Patents

Verfahren und kit zum nachweis, oder zum quantifizieren von, metaboliten von fentanyl und metaboliten von fentanyl analoga

Info

Publication number
ATE358275T1
ATE358275T1 AT02079785T AT02079785T ATE358275T1 AT E358275 T1 ATE358275 T1 AT E358275T1 AT 02079785 T AT02079785 T AT 02079785T AT 02079785 T AT02079785 T AT 02079785T AT E358275 T1 ATE358275 T1 AT E358275T1
Authority
AT
Austria
Prior art keywords
metabolites
fentanyl
kit
detecting
quantifying
Prior art date
Application number
AT02079785T
Other languages
English (en)
Inventor
Robert Ivan Mcconnell
El Ouard Benchikh
Stephen Peter Fitzgerald
John Victor Lamont
Original Assignee
Randox Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Lab Ltd filed Critical Randox Lab Ltd
Application granted granted Critical
Publication of ATE358275T1 publication Critical patent/ATE358275T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
AT02079785T 2001-11-16 2002-11-15 Verfahren und kit zum nachweis, oder zum quantifizieren von, metaboliten von fentanyl und metaboliten von fentanyl analoga ATE358275T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204401 2001-11-16

Publications (1)

Publication Number Publication Date
ATE358275T1 true ATE358275T1 (de) 2007-04-15

Family

ID=8181257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02079785T ATE358275T1 (de) 2001-11-16 2002-11-15 Verfahren und kit zum nachweis, oder zum quantifizieren von, metaboliten von fentanyl und metaboliten von fentanyl analoga

Country Status (5)

Country Link
US (1) US7109310B2 (de)
CN (1) CN100402084C (de)
AT (1) ATE358275T1 (de)
DE (1) DE60219124T2 (de)
ES (1) ES2284783T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1588145B1 (de) * 2003-01-30 2011-07-06 Life Technologies Corporation Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung
US20060040406A1 (en) * 2004-02-17 2006-02-23 David Schneider Narcotic analgesic tracking system
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
MX347741B (es) * 2008-09-16 2017-05-10 Nektar Therapeutics Opioides pegilados con bajo potencial de abuso.
ES2523896T3 (es) * 2010-02-02 2014-12-02 Randox Laboratories Ltd. Inmunoensayo de zolpidem con ventana de detección extendida
CN102249986B (zh) * 2011-02-28 2016-06-22 华东理工大学 N-苯乙基-4-苯胺基哌啶的制备方法
GB201313938D0 (en) 2013-08-05 2013-09-18 Randox Lab Ltd Immunoassay for phenethylamines of the 2C and DO sub-families
GB201409516D0 (en) 2014-05-29 2014-07-16 Randox Lab Ltd Immunoassay for compounds of the NBOMe family
US11305010B2 (en) * 2016-01-21 2022-04-19 The Scripps Research Institute Synthetic opioid vaccine
US11660331B2 (en) 2017-11-09 2023-05-30 The Scripps Research Institute Heroin vaccine
CN115210557A (zh) * 2019-10-21 2022-10-18 韦里特克美国有限公司 芬太尼类似物检测方法及其试剂盒
WO2021092446A1 (en) * 2019-11-08 2021-05-14 Regents Of The University Of Minnesota Fentanyl hapten, fentanyl hapten-conjugates, and methods for making and using
US20230100186A1 (en) * 2020-01-13 2023-03-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Fentanyl haptens for the preparation of a fentanyl vaccine
CN111257574B (zh) * 2020-03-04 2024-01-16 中检国研(北京)科技有限公司 用于芬太尼类物质快速筛查的荧光免疫快检卡及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0363041A1 (de) * 1988-09-21 1990-04-11 Ube Industries, Ltd. Monoklonaler Antikörper gegen Morphin, Bereitung von monoklonalen Antikörpern, Testsatz und Verfahren zur Bestimmung von Morphin
AU6044496A (en) * 1995-06-05 1996-12-24 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opi oid agonistic activity
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain

Also Published As

Publication number Publication date
DE60219124T2 (de) 2008-01-31
CN100402084C (zh) 2008-07-16
CN1428607A (zh) 2003-07-09
DE60219124D1 (de) 2007-05-10
US7109310B2 (en) 2006-09-19
US20030170728A1 (en) 2003-09-11
ES2284783T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
DE60219124D1 (de) Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga
ATE551352T1 (de) Peptidakzeptorbindungsverfahren
ATA8612001A (de) Verfahren zum testen von software
ATE256658T1 (de) Funktionelle vitamin-d-derivate und verfahren zur bestimmung von 25-hydroxy- und 1alpha,25- dihydroxy-vitamin-d
WO2000002917A3 (en) Compounds and methods for modulating cadherin-mediated functions
EP1216218A4 (de) Verfahren zur anreicherung von kohlenwasserstoffen
ATE465410T1 (de) Vorrichtungen und verfahren zum nachweis von fruchtwasser in vaginalsekreten
DE60126337D1 (de) Verfahren zum screenen für gpr40-liganden
DE58905253D1 (de) Verfahren zum verstellen von reibungskupplungen oder -bremsen.
DE60207016D1 (de) Verfahren und Kit zur Quantifizierung von Beta-Laktam Penizillinen
DE50104426D1 (de) Verfahren zur vernetzung von polyacrylaten
AR042652A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
FI884720A0 (fi) Kompositioner foer anvaendning som kontrastmedel.
DE50115254D1 (de) Verfahren zum erkennen und/oder begrenzen von kurzndler
DK0393304T3 (da) Fremgangsmåde til foring af et underjordisk ledningsrør
EP1305625A4 (de) Verfahren zum immunnachweis von epitopen
ATE539350T1 (de) Verfahren zum nachweis oder zum bestimmen von hbv
ATE370411T1 (de) Verfahren zum screening
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE69022774D1 (de) Verfahren zur Untergrundkorrektur zum Gebrauch in der Gaschromatographie.
EP1728349A4 (de) Verfahren zur verkürzung der durchlaufzeit eines ausführungselements durch einen kontrollpunkt
DE50101211D1 (de) Abklebewerkzeug und verfahren zum automatisierten, serienmässigen applizieren von klebeband
EP1312923A3 (de) Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analogen
MXPA01009272A (es) Procedimiento de deformacion permanente de materias queratinicas que utiliza un agente absorbente organico.
DE50106697D1 (de) Verfahren zum auffinden von objekten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties